Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) is now available.
Recordati S.p.A. has provided an update on its share buyback program, which was initiated to support stock option and performance share plans for the company’s management. As of October 10, 2025, Recordati has purchased 20,895 shares, holding a total of 4,547,996 own shares, representing 2.175% of its share capital. This move is part of Recordati’s strategy to incentivize management and align their interests with those of shareholders, potentially impacting the company’s market positioning and stakeholder relations.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR58.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, originating from a family-run pharmacy in Northern Italy. It offers therapeutic options in general and specialist medicine, as well as rare diseases, and is involved in clinical development, production, marketing, and licensing of active pharmaceutical ingredients and finished products. The company operates in about 150 countries across the EMEA, Americas, and APAC regions, with over 4,580 employees.
Average Trading Volume: 235,809
Technical Sentiment Signal: Buy
Current Market Cap: €10.78B
For detailed information about REC stock, go to TipRanks’ Stock Analysis page.